SK51296A3 - Inhibiting photodecomposition of 3-substituted-2-oxindol-1- -carboxamides, a tablet and a capsule - Google Patents

Inhibiting photodecomposition of 3-substituted-2-oxindol-1- -carboxamides, a tablet and a capsule Download PDF

Info

Publication number
SK51296A3
SK51296A3 SK512-96A SK51296A SK51296A3 SK 51296 A3 SK51296 A3 SK 51296A3 SK 51296 A SK51296 A SK 51296A SK 51296 A3 SK51296 A3 SK 51296A3
Authority
SK
Slovakia
Prior art keywords
red
light
chlorine
yellow
hydrogen
Prior art date
Application number
SK512-96A
Other languages
English (en)
Slovak (sk)
Inventor
Willard C Newlin Jr
Sharon M Laughlin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SK51296A3 publication Critical patent/SK51296A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883Capsule finishing, e.g. dyeing, aromatising, polishing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymerisation Methods In General (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
SK512-96A 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindol-1- -carboxamides, a tablet and a capsule SK51296A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB1995/000287 WO1996033701A1 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindoles

Publications (1)

Publication Number Publication Date
SK51296A3 true SK51296A3 (en) 1997-04-09

Family

ID=36997502

Family Applications (1)

Application Number Title Priority Date Filing Date
SK512-96A SK51296A3 (en) 1995-04-24 1995-04-24 Inhibiting photodecomposition of 3-substituted-2-oxindol-1- -carboxamides, a tablet and a capsule

Country Status (30)

Country Link
EP (1) EP0827399A1 (tr)
JP (1) JPH10506635A (tr)
KR (1) KR100189585B1 (tr)
CN (1) CN1053667C (tr)
AP (1) AP607A (tr)
AR (1) AR002728A1 (tr)
AU (1) AU692378B2 (tr)
BG (1) BG100531A (tr)
BR (1) BR9602024A (tr)
CO (1) CO4700418A1 (tr)
FI (1) FI973988A7 (tr)
HR (1) HRP960194A2 (tr)
HU (1) HU216544B (tr)
IL (1) IL117969A0 (tr)
IS (1) IS4339A (tr)
MA (1) MA23848A1 (tr)
NO (1) NO961622L (tr)
NZ (1) NZ286432A (tr)
OA (1) OA10286A (tr)
PE (1) PE34397A1 (tr)
RO (1) RO113305B1 (tr)
RU (1) RU2109510C1 (tr)
SG (1) SG64924A1 (tr)
SI (1) SI9600133A (tr)
SK (1) SK51296A3 (tr)
TR (1) TR199600300A2 (tr)
UA (1) UA42739C2 (tr)
WO (1) WO1996033701A1 (tr)
YU (1) YU25096A (tr)
ZA (1) ZA963210B (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020006768A (es) 2017-12-29 2020-08-24 Kraft Foods Group Brands Llc Estabilidad oxidativa mejorada de emulsiones de aceite-en-agua utilizando estabilizadores naturales.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3136282A1 (de) * 1981-09-12 1983-03-24 Hoechst Ag "verfahren zur stabilisierung photoinstabiler arzneistoffe sowie stabilisierte arzneizubereitungen"
HUT59592A (en) * 1990-07-20 1992-06-29 Egyt Gyogyszervegyeszeti Gyar Process for the preparation of solid medical products
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Also Published As

Publication number Publication date
HUP9601057A2 (en) 1997-04-28
AP607A (en) 1997-08-27
HU216544B (hu) 1999-07-28
UA42739C2 (uk) 2001-11-15
CN1139110A (zh) 1997-01-01
KR960037656A (ko) 1996-11-19
RO113305B1 (ro) 1998-06-30
EP0827399A1 (en) 1998-03-11
NZ286432A (en) 1998-05-27
FI973988A0 (fi) 1997-10-17
AU5085196A (en) 1996-11-07
IL117969A0 (en) 1996-08-04
AP9600787A0 (en) 1996-04-30
OA10286A (en) 1997-09-19
CO4700418A1 (es) 1998-12-29
SI9600133A (en) 1996-10-31
BG100531A (bg) 1997-06-30
WO1996033701A1 (en) 1996-10-31
PE34397A1 (es) 1997-09-29
SG64924A1 (en) 1999-05-25
FI973988L (fi) 1997-10-17
YU25096A (sh) 1998-08-14
IS4339A (is) 1996-10-25
HUP9601057A3 (en) 1997-05-28
HU9601057D0 (en) 1996-06-28
BR9602024A (pt) 1998-10-06
RU2109510C1 (ru) 1998-04-27
ZA963210B (en) 1997-10-23
TR199600300A2 (tr) 1996-11-21
HRP960194A2 (en) 1998-02-28
CN1053667C (zh) 2000-06-21
JPH10506635A (ja) 1998-06-30
AR002728A1 (es) 1998-04-29
KR100189585B1 (ko) 1999-06-01
MA23848A1 (fr) 1996-12-31
FI973988A7 (fi) 1997-10-17
NO961622L (no) 1996-10-25
NO961622D0 (no) 1996-04-23
AU692378B2 (en) 1998-06-04

Similar Documents

Publication Publication Date Title
US7932289B2 (en) Remedy for diabetes
RS66566B1 (sr) Farmaceutska kombinacija i kompozicija, i kombinovani preparat koji sadrži aktivator glukokinaze i biguanid hipoglikemijski lek kao i postupak njihove pripreme i upotrebe
CA2501587C (en) Solid preparation having phase containing insulin sensitizer and another active ingredient uniformly mixed
MXPA06013711A (es) Formulacion de tableta revestida y metodo.
CA2617715A1 (en) Pharmaceutical composition comprising a dpp-iv inhibitor
SK23697A3 (en) Pharmaceutical formulations, a method of producing thereof and its use
JP4739189B2 (ja) 固形製剤
NL8600302A (nl) Farmaceutische preparaten met analgetische werkzaamheid, alsmede de bereiding en toepassing ervan.
SK51296A3 (en) Inhibiting photodecomposition of 3-substituted-2-oxindol-1- -carboxamides, a tablet and a capsule
CA2216931A1 (en) Inhibiting photodecomposition of 3-substituted-2-oxindoles
US4333945A (en) Thiazoline and imidazoline derivatives useful as minor tranquilizers
EP1946778A1 (en) Active substance combination for the treatment of diabetes
US20250099451A1 (en) Pharmaceutical composition of a cyp11a1 inhibitor
AU620658B2 (en) Memory-enhancing compositions containing dioxopiperidine derivatives
KR20250159949A (ko) 안정성이 개선된 피타바스타틴을 포함하는 약학 조성물
SU1648475A1 (ru) Состав дл покрыти твердых лекарственных форм
JPS6323969B2 (tr)
JPS5813511A (ja) 光不安定性医薬の被包用軟カプセル
TH13801A (th) สารผสมทางเภสัชกรรมที่เสถียรซึ่งประกอบด้วยสารยับยั้ง HMG-CoA รีดักเตส
MXPA97008155A (en) Inhibition of the photo-composition of 2-oxindoles 3-substitute
BG860Y1 (bg) Лекарствена форма на дипиридамол
TH11684B (th) สารผสมทางเภสัชกรรมที่เสถียรซึ่งประกอบด้วยสารยับยั้ง HMG-CoA รีดักเตส
HK1080385B (en) Solid preparation